Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership469,388 shares
Latest Disclosed Value $ 155,306,467
Goldman Sachs Group Inc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 469,388 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $134,104,152 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 374,760 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 25.25% during the quarter. The current value of the position is $122,275,574 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 469,388 94,628 25.25 155,306 4.22 0.0042
2026-02-10 2025-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 374,760 -163,586 -30.39 149,023 -39.29 0.0184
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 538,346 -6,970 -1.28 245,486 38.05 0.0300
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 545,316 121,949 28.80 177,822 55.55 0.0242
2025-06-27 2025-03-31 13F/A-2 ALNYLAM PHARMACEUTICALS CMN 02043Q107 423,367 116,912 38.15 114,318 58.53 0.0185
2025-05-16 2025-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 423,367 116,912 114,318 0.0185
2025-05-09 2025-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 455,367 148,912 122,958 0.0037
2025-02-11 2024-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 306,455 -49,645 -13.94 72,112 -26.37 0.0114
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 356,100 -158,567 -30.81 97,938 -21.69 0.0158
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 514,667 254,648 97.93 125,064 221.84 0.0211
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 260,019 -31,349 -10.76 38,860 -30.32 0.0069
2024-05-14 2023-12-31 13F/A-2 ALNYLAM PHARMACEUTICALS CMN 02043Q107 291,368 -20,677 -6.63 55,771 0.92 0.0103
2024-03-01 2023-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 291,368 -20,677 55,771 0.0100
2024-02-13 2023-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 291,368 -20,677 55,771 0.0026
2024-05-15 2023-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 312,045 56,152 21.94 55,263 13.70 0.0118
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 312,045 56,152 55,263 0.0111
2024-05-14 2023-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 255,893 25,707 11.17 48,604 5.41 0.0104
2023-08-15 2023-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 255,893 25,707 48,604 0.0098
2024-05-14 2023-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 230,186 -162,575 -41.39 46,111 -50.60 0.0106
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 230,186 -162,575 46,111 0.0098
2024-05-14 2022-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 392,761 -72,546 -15.59 93,340 100,264.52 0.0229
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 392,761 -72,546 93,340 0.0209
2024-05-14 2022-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 465,307 -12,067 -2.53 93 34.78 0.0235
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 465,307 -12,067 93,136 0.0215
2024-05-14 2022-06-30 13F/A-2 ALNYLAM PHARMACEUTICALS CMN 02043Q107 477,374 -204,179 -29.96 70 -99.94 0.0174
2022-08-18 2022-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 477,374 -204,179 69,626 0.0157
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 477,374 -204,179 69,626 0.0157
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 681,553 -5,142 -0.75 111,290 -4.43 0.0234
2022-02-17 2021-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 686,695 20,240 3.04 116,450 -7.46 0.0231
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 686,695 20,240 116,450 0.0067
2022-01-20 2021-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 666,455 -35,591 -5.07 125,834 5.73 0.0267
2021-11-10 2021-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 666,455 -35,591 125,834 0.0266
2021-08-13 2021-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 702,046 7,736 1.11 119,011 21.40 0.0267
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 694,310 -19,075 -2.67 98,029 5.73 0.0247
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 713,385 125,825 21.41 92,719 8.38 0.0239
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 587,560 -497,516 -45.85 85,549 -46.77 0.0243
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,085,076 304,814 39.07 160,711 89.22 0.0488
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 780,262 -57,442 -6.86 84,932 -11.97 0.0299
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 837,704 -309,664 -26.99 96,479 4.56 0.0246
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,147,368 227,197 24.69 92,271 38.20 0.0267
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 920,171 -96,842 -9.52 66,768 -29.75 0.0192
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,017,013 -102,375 -9.15 95,040 16.45 0.0287
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,119,388 178,810 19.01 81,615 -0.86 0.0260
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 940,578 111,679 13.47 82,319 0.83 0.0213
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 828,899 -181,839 -17.99 81,638 -32.18 0.0221
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,010,738 -176,806 -14.89 120,379 -20.21 0.0308
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,187,544 -606,207 -33.80 150,877 -28.41 0.0361
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,793,751 282,039 18.66 210,748 74.79 0.0516
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,511,712 127,718 9.23 120,575 69.99 0.0312
2017-05-18 2017-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,383,994 469,557 51.35 70,930 107.17 0.0192
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 1,383,994 70,930
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 914,437 -28,422 -3.01 34,237 -46.43 0.0097
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 942,859 249,691 36.02 63,907 66.15 0.0194
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 693,168 51,294 7.99 38,464 -4.53 0.0126
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 641,874 248,739 63.27 40,291 8.87 0.0132
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 393,135 67,369 20.68 37,009 41.37 0.0116
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 325,766 -59,811 -15.51 26,178 -43.36 0.0088
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 385,577 -209,528 -35.21 46,219 -25.62 0.0143
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 595,105 38,829 6.98 62,141 15.16 0.0200
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 556,276 -14,829 -2.60 53,959 20.97 0.0171
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 571,105 7,994 1.42 44,604 25.39 0.0142
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 563,111 50,522 9.86 35,571 3.36 0.0111
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 512,589 71,839 16.30 34,415 21.44 0.0113
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 440,750 91,961 26.37 28,340 26.94 0.0093
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 348,789 -203,530 -36.85 22,326 30.39 0.0082
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS CMN 02043Q107 552,319 362,494 190.96 17,122 394.14 0.0066
2013-06-14 2012-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 189,825 -34,329 -15.31 3,465 -17.72 0.0014
2013-06-14 2012-09-30 13F/A-2 ALNYLAM PHARMACEUTICALS CMN 02043Q107 224,154 6,807 3.13 4,211 66.31 0.0017
2013-06-14 2012-06-30 13F/A-2 ALNYLAM PHARMACEUTICALS CMN 02043Q107 217,347 184,557 562.85 2,532 597.52 0.0011
2013-06-14 2012-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS CMN 02043Q107 32,790 32,790 363 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 20,900 30.62 6,815 57.75 n/a n/a n/a
2025-05-16 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Call 16,000 4,320 n/a n/a n/a
2025-06-27 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Call 16,000 4,320 n/a n/a n/a
2022-01-20 2021-09-30 13F/A ALNYLAM PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-10 2021-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 0 0 n/a n/a n/a
2021-08-13 2021-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 25,000 -16.67 4,238 0.05 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS CMN Call 30,000 -53.85 4,236 -49.86 n/a n/a n/a
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 65,000 44.44 8,448 28.94 n/a n/a n/a
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 45,000 516.44 6,552 506.11 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 7,300 -29.81 1,081 -4.51 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS CMN Call 10,400 -92.24 1,132 -92.67 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 134,000 -67.61 15,433 -53.61 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 413,700 397.83 33,270 451.74 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 83,100 -51.43 6,030 -62.29 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS CMN Call 171,100 129.97 15,989 194.73 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 74,400 435.25 5,425 345.77 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 13,900 0.00 1,217 -11.10 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 13,900 1,369 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 76,600 9,000 n/a n/a n/a
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 178,400 -45.54 12,092 -33.48 n/a n/a n/a
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 327,600 0.18 18,179 -11.43 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS CMN Call 327,000 717.50 20,526 445.03 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 40,000 -67.08 3,766 -61.43 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 121,500 -7.60 9,764 -38.06 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 131,500 15.55 15,763 32.65 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS CMN Call 113,800 -13.59 11,883 -6.98 n/a n/a n/a
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS CMN Call 131,700 -66.70 12,775 -58.64 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 395,500 10.47 30,889 36.59 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 358,000 199.83 22,615 195.89 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS CMN Call 119,400 455.35 7,643 1,045.88 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS CMN Call 21,500 667 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 30,000 87.50 9,783 126.44 n/a n/a n/a
2025-06-27 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Put 16,000 4,320 n/a n/a n/a
2025-05-16 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Put 16,000 4,320 n/a n/a n/a
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 25,000 3,736 n/a n/a n/a
2024-05-14 2023-06-30 13F/A ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-15 2023-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 0 0 n/a n/a n/a
2024-05-14 2023-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Put 20,000 4,006 n/a n/a n/a
2023-05-11 2023-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 20,000 4,006 n/a n/a n/a
2022-02-17 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 0 0 n/a n/a n/a
2022-01-20 2021-09-30 13F/A ALNYLAM PHARMACEUTICALS CMN Put 4,000 -86.21 755 -84.64 n/a n/a n/a
2021-11-10 2021-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 4,000 755 n/a n/a n/a
2021-08-13 2021-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 29,000 -3.33 4,916 16.05 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 30,000 -25.00 4,236 -18.52 n/a n/a n/a
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 40,000 5,199 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 34,700 155.15 3,996 265.27 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 13,600 0.00 1,094 10.84 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 13,600 0.00 987 -22.34 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 13,600 0.00 1,271 28.13 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 13,600 0.00 992 -16.64 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 13,600 -78.62 1,190 -81.00 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 63,600 6,264 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 12,600 -61.35 1,601 -58.20 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 32,600 158.73 3,830 281.09 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 12,600 46.51 1,005 127.89 n/a n/a n/a
2017-05-18 2017-03-31 13F/A ALNYLAM PHARMACEUTICALS CMN Put 8,600 0.00 441 36.96 n/a n/a n/a
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 8,600 441 n/a n/a n/a
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 8,600 -57.00 322 -76.25 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 20,000 -85.24 1,356 -81.97 n/a n/a n/a
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 135,500 -29.72 7,519 -37.87 n/a n/a n/a
2016-05-13 2016-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 192,800 382.00 12,102 221.35 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 40,000 -20.00 3,766 -6.27 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 50,000 -27.43 4,018 -51.35 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 68,900 -13.22 8,259 -0.39 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS CMN Put 79,400 100.00 8,291 115.29 n/a n/a n/a
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS CMN Put 39,700 -79.95 3,851 -75.10 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 198,000 25.32 15,464 54.93 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS CMN Put 158,000 32.33 9,981 30.59 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS CMN Put 119,400 7,643 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.